The Accuracy of Clinical Staging of Stage I-IIIa Non-Small Cell Lung Cancer An Analysis Based on Individual Participant Data

[1]  M. Oudkerk,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.

[2]  Jérémie F. Cohen,et al.  Added value of combined endobronchial and oesophageal endosonography for mediastinal nodal staging in lung cancer: a systematic review and meta-analysis. , 2016, The Lancet. Respiratory medicine.

[3]  M. Wouters,et al.  The Quality of Staging Non-Small Cell Lung Cancer in the Netherlands: Data From the Dutch Lung Surgery Audit. , 2016, The Annals of thoracic surgery.

[4]  H. Groen,et al.  Patterns of Recurrence and Survival after Surgery or Stereotactic Radiotherapy for Early Stage NSCLC , 2015, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[5]  D. Baldwin,et al.  FDG-PET/CT imaging for mediastinal staging in patients with potentially resectable non-small cell lung cancer. , 2015, JAMA.

[6]  M. Parmar,et al.  Lung cancer diagnosis and staging with endobronchial ultrasound-guided transbronchial needle aspiration compared with conventional approaches: an open-label, pragmatic, randomised controlled trial , 2015, The Lancet. Respiratory medicine.

[7]  L. Portney,et al.  Foundations of Clinical Research: Applications to Practice , 2015 .

[8]  Leslie G. Portney Dpt PhD Fapta,et al.  Foundations of Clinical Research: Applications to Practice , 2015 .

[9]  Sarah Burdett,et al.  Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data , 2014, The Lancet.

[10]  D. de Ruysscher,et al.  Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

[11]  L. Tanoue,et al.  Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. , 2013, Chest.

[12]  C. Dooms,et al.  Mediastinoscopy vs endosonography for mediastinal nodal staging of lung cancer: a randomized trial. , 2010, JAMA.

[13]  H. Groen,et al.  Inaccurate clinical nodal staging of non-small cell lung cancer: evidence from the MRC LU22 multicentre randomised trial , 2010, Thorax.

[14]  J. Crowley,et al.  Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  Andrea Bezjak,et al.  Stereotactic body radiation therapy for inoperable early stage lung cancer. , 2010, JAMA.

[16]  Keith M Godfrey,et al.  Validation of a maternal questionnaire on correlates of physical activity in preschool children , 2009, The international journal of behavioral nutrition and physical activity.

[17]  Nasser K. Altorki,et al.  Point: Clinical stage IA non-small cell lung cancer determined by computed tomography and positron emission tomography is frequently not pathologic IA non-small cell lung cancer: the problem of understaging. , 2009, The Journal of thoracic and cardiovascular surgery.

[18]  Carlo Bartolozzi,et al.  Response to radiofrequency ablation of pulmonary tumours: a prospective, intention-to-treat, multicentre clinical trial (the RAPTURE study). , 2008, The Lancet. Oncology.

[19]  O. Dalesio,et al.  Preoperative chemotherapy in patients with resectable non-small cell lung cancer: results of the MRC LU22/NVALT 2/EORTC 08012 multicentre randomised trial and update of systematic review , 2007, The Lancet.

[20]  P. V. Van Schil,et al.  ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[21]  R. Cerfolio,et al.  Improving the inaccuracies of clinical staging of patients with NSCLC: a prospective trial. , 2005, The Annals of thoracic surgery.

[22]  Yi-long Wu,et al.  P-645 A randomized trial comparing neoadjuvant gemicitabine plus carboplatin or cisplatin followed by surgery with surgery alone in Clinical Stage IIIA non-small-cell lung cancer (NSCLC) , 2005 .

[23]  J. Rivas,et al.  Comparison between clinical and pathologic staging in 2,994 cases of lung cancer. , 2005, The Annals of thoracic surgery.

[24]  Robert D Timmerman,et al.  Stereotactic body radiation therapy. , 2004, Current problems in cancer.

[25]  H. Kato,et al.  A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209). , 2003, The Journal of thoracic and cardiovascular surgery.

[26]  G. T. ten Velde,et al.  Docetaxel as neoadjuvant therapy for radically treatable stage III non-small-cell lung cancer: a multinational randomised phase III study. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  B. Nathwani,et al.  Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the Non-Hodgkin's Lymphoma Classification Project. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

[28]  E. Lemarié,et al.  Preoperative chemotherapy followed by surgery compared with primary surgery in resectable stage I (except T1N0), II, and IIIa non-small-cell lung cancer. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  Orit Shechtman,et al.  Foundations of Clinical Research: Applications to Practice, 2nd Edition, Leslie Gross Portney, Mary P. Watkins. Prentice Hall, Upper Saddle River, NJ (2000), 752 pages. $60 , 2001 .

[30]  E. Smit,et al.  Randomized multicenter phase II study of chemotherapy followed by surgery versus surgery alone in stage I and II non-small cell lung cancer (NSCLC) , 2000 .

[31]  J. Roth,et al.  A randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer. , 1994, Journal of the National Cancer Institute.

[32]  L. Sobin,et al.  TNM Classification of Malignant Tumours , 1987, UICC International Union Against Cancer.